OKUR
OnKure Therapeutics
OKUR
OKUR
33 hedge funds and large institutions have $43.3M invested in OnKure Therapeutics in 2022 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 5 increasing their positions, 12 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
50% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 14
58% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 12
Holders
33
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$457K | |
| 2 | +$158K | |
| 3 | +$142K | |
| 4 |
Barclays
London,
United Kingdom
|
+$134K |
| 5 |
E
Ergoteles
New York
|
+$112K |
Top Sellers
| 1 | -$2.06M | |
| 2 | -$779K | |
| 3 | -$191K | |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
-$179K |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$147K |